August 7, 2020
August 7, 2020 –
The U.S. FDA has approved Lampit® (nifurtimox), manufactured by Bayer, to treat
pediatric patients who weigh at least 2.5kg (5.5 pounds) and
August 7, 2020
August 7, 2020 –
The U.S. FDA has approved EvrysdiTM (risdiplam), manufactured by Genentech, to treat spinal muscular atrophy (SMA) in patients who are at least two months old.
August 6, 2020
August 6, 2020 –
The U.S. FDA has approved BlenrepTM (belantamab mafodotin-blmf), manufactured by
GlaxoSmithKline, for use as a single agent to treat adults who have
August 6, 2020
August 6, 2020 –
The U.S. FDA has approved an expanded indication for Dovato® (dolutegravir/
lamivudine) oral tablets, manufactured by ViiV Healthcare. The drug is
August 3, 2020
August 3, 2020 –
The U.S. FDA has approved Monjuvi® (tafasitamab-cxix), manufactured by MorphoSys
AG and Incyte, for use in combination with lenalidomide to treat adults
August 3, 2020
August 3, 2020 – The U.S. FDA has approved a new indication for Spravato® (esketamine) nasal spray,
manufactured by Janssen Pharmaceuticals. Spravato is now indicated for
July 30, 2020
July 30, 2020 –
The U.S. FDA has approved a new indication for Tecentriq® (atezolizumab), manufactured
by Genetech. Tecentriq is now indicated for use with Genetech’s Cotellic®
July 30, 2020
July 30, 2020 –
The U.S. FDA has approved an expanded indication for Stelara® (ustekinumab), manufactured by Janssen Pharmaceuticals. The drug is now indicated to